Open AccessLong-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
Author(s) -
Kevin Winthrop,
Séverine Vermeire,
Millie D. Long,
Julián Panés,
Siew C. Ng,
Nicole Kulisek,
Rajiv Mundayat,
Nervin Lawendy,
Ivana Vranić,
Irene Modesto,
Chinyu Su,
Gil Y. Melmed
Publication year - 2022
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izac063
Subject(s) - tofacitinib , janus kinase inhibitor , medicine , ulcerative colitis , incidence (geometry) , gastroenterology , cohort , proportional hazards model , rheumatoid arthritis , physics , disease , optics